ArticleFrontiers in oncology2026
A coupled iron-hypoxia selection model for the evolution of endometriosis-associated ovarian clear cell carcinoma.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Ovarian clear cell carcinoma (OCCC) frequently arises in association with endometriosis and is characterized by iron-rich oxidative stress, hypoxia-responsive metabolic reprogramming, glycogen accumulation, and alterations in ferroptosis-regulatory pathways. Interactions among hypoxia, iron metabolism, oxidative stress, and ferroptosis are increasingly recognized, but their role during precursor evolution remains uncertain. Hypothesis: We propose that chronic iron-rich oxidative stress and a hypoxic microenvironment may jointly alter the relative fitness of epithelial cells during the endometriosis-to-OCCC transition. Repeated exposure may create a putative ferroptosis-related selection filter that preferentially removes susceptible cells while enriching less-susceptible cellular subpopulations capable of sustained survival. Here, ferroptosis tolerance denotes relative survival under chronic or sublethal ferroptosis-related stress and does not imply experimentally demonstrated resistance; broader oxidative-stress adaptation alone is insufficient to establish it. Surviving populations may acquire an adaptive iron-handling state that constrains the metabolically available labile iron pool despite an iron-rich extracellular environment through changes in iron uptake, ferritin-mediated sequestration and turnover, mitochondrial utilization, cellular export, or extracellular-vesicle-mediated ferritin disposal. These mechanisms may cooperate with HIF-1α/SLC1A1-associated adaptation and NRF2/SLC7A11/GPX4/glutathione pathways. Loss-of-function alteration of Discussion: The novelty of this framework lies not in any single molecular interaction, but in applying interconnected iron, hypoxia, redox, and ferroptosis biology to an evolutionary selection model across the endometriosis-atypical endometriosis-OCCC continuum. The model predicts coordinated stress and iron-handling adaptations in precursor lesions, reproducible changes in population composition after repeated sublethal iron-hypoxia exposure, and, as a distinct outcome, durable phenotypic adaptation after washout. These predictions can be tested through cyst-fluid analysis, spatial profiling, and repeated-exposure, washout, rechallenge, and lineage-tracing experiments. The framework is a falsifiable hypothesis that may be supported, narrowed, reformulated, or rejected experimentally.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.